Conference ADA 2022

• A recommendation about adequate carbohydrate intake prior to oral glucose tolerance testing as a screen for diabetes was added, with supportive references added to the text (Recommendations 2.4 and 2.12).

17. 2.12       When using oral glucose tolerance testing as a screen for diabetes, adequate carbohydrate intake (at least 150 g/ day) should be assured for 3 days prior to testing. A
17. 2.4 Adequate carbohydrate intake (at least 150 g/day) should be assured for 3 days prior to oral glucose tolerance testing as a screen for diabetes. A

• The discussion regarding use of point-of-care A1C assays for the diagnosis of diabetes has been revised.

17. Point-of-care A1C assays may be NGSP certified and cleared by the U.S. Food and Drug Administration (FDA) for use in monitoring glycemic control in people with diabetes in both Clinical Laboratory Improvement Amendments (CLIA)-regulated and CLIA-waived settings.
17. Point-of-care A1C assays have not been prospectively studied for the diagnosis of diabetes and are not recommended for diabetes diagnosis; if used, they should be confirmed with a validated measure

• Exclude POCA1c as a test for diagnosis of diabetes.